Suggestions

pharmaglobenews

pharmaglobenews

Tumour Necrosis Factor Ligand Superfamily Member 15 Inhibitor Market Set for Growth as RG6631 Advances Toward Late-Stage Development

The global Tumour Necrosis Factor Ligand Superfamily Member 15 (TNFSF15) inhibitor market is emerging as a promising segment within the broader inflammatory and autoimmune therapeutics landscape, driven by growing interest in targeted treatment approaches for ulcerative colitis, Crohn’s disease, and metabolic dysfunction-associated
1 September 2026

Thyroid Gland Disorder Treatment Market: Rising Prevalence, R&D Breakthroughs, and Expanding Therapeutic Pipeline Drive Robust Global Growth Through 2032

Thyroid Gland Disorder Treatment Market Overview Thyroid Gland Disorder Treatment Market by Drug Type (Levothyroxine, Liothyronine, Propylthiouracil, Methimazole, Carbimazole, and Others), Disorder Type (Hypothyroidism and Hyperthyroidism), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital and Retail Pharmacies and Online Pharmacies), and
27 August 2026

The Global Cardiac Monitoring Devices Market Size is projected to grow at a CAGR of 4.35% during the forecast period from 2026 to 2034 | DelveInsight

DelveInsight’s Cardiac Monitoring Devices Market Insights Report 2034 provides the current and forecast market analysis, individual leading Cardiac Monitoring Devices companies’ market shares, challenges, Cardiac Monitoring Devices Market Drivers, barriers, trends, and key market Cardiac Monitoring Devices companies in the market. To
27 August 2026

The Global Ophthalmic Laser Devices Market Size is projected to grow at a CAGR of 4.44% during the forecast period from 2024 to 2030 | DelveInsight

DelveInsight’s Ophthalmic Laser Devices Market Insights Report 2030 provides the current and forecast market analysis, individual leading Ophthalmic Laser Devices companies’ market shares, challenges, Ophthalmic Laser Devices Market Drivers, barriers, trends, and key market Ophthalmic Laser Devices companies in the market. To
26 August 2026

Transcatheter Aortic Valve Replacement Market to Reach USD 7.64 Billion by 2032, Driven by Rising Aortic Stenosis Burden and Expanding TAVR Adoption

Global Transcatheter Aortic Valve Replacement (TAVR) Market is witnessing remarkable growth as increasing prevalence of aortic stenosis, expanding indications for minimally invasive cardiac procedures, and continuous technological innovations accelerate demand for next-generation transcatheter heart valves worldwide. DelveInsight’s latest market analysis reports that
25 August 2026
1 … 4 5 6 7 8 … 43

    Banner

    Newsletter